Design, optimization and validation of compounds against cancer-Initiating cells. - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

12985.1;6 PFLS-LS

Project title

Design, optimization and validation of compounds against cancer-Initiating cells.

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-

Inserted texts

Category	Text
Short description (German)	Design, optimization and validation of compounds against cancer-Initiating cells.
Short description (English)	Design, optimization and validation of compounds against cancer-Initiating cells.
Abstract (German)	This CTI project aims at identifying a preclinical candidate and generate a selection of back-up compounds to treat brain cancer, in order to accelerate and improve the development programs of Stemergie Biotechnology SA. The combination of the unique technology expertise of Stemergie in cancer-initiating cells with the medicinal chemistry technologies and know-how of the Carreira Group at the ETH Zurich shall enable the development of novel drug candidates to treat brain cancer patients.
Abstract (English)	This CTI project aims at identifying a preclinical candidate and generate a selection of back-up compounds to treat brain cancer, in order to accelerate and improve the development programs of Stemergie Biotechnology SA. The combination of the unique technology expertise of Stemergie in cancer-initiating cells with the medicinal chemistry technologies and know-how of the Carreira Group at the ETH Zurich shall enable the development of novel drug candidates to treat brain cancer patients.